Clinical Characteristics and Mechanism Research of Inhibitors of Janus Kinase in the Idiopathic Inflammatory Myopathies
NCT05400889
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Idiopathic Inflammatory Myopathies
Interventions
DRUG:
tofacitinib
Sponsor
Peking University People's Hospital